PNC Financial Services Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-97
| Closed | -$7K | – | 4725 |
|
2022
Q2 | $7K | Sell |
97
-8,449
| -99% | -$610K | ﹤0.01% | 3924 |
|
2022
Q1 | $230K | Buy |
8,546
+888
| +12% | +$23.9K | ﹤0.01% | 2161 |
|
2021
Q4 | $364K | Sell |
7,658
-28
| -0.4% | -$1.33K | ﹤0.01% | 1891 |
|
2021
Q3 | $511K | Buy |
7,686
+84
| +1% | +$5.59K | ﹤0.01% | 1593 |
|
2021
Q2 | $594K | Buy |
7,602
+2,482
| +48% | +$194K | ﹤0.01% | 1494 |
|
2021
Q1 | $484K | Buy |
5,120
+460
| +10% | +$43.5K | ﹤0.01% | 1588 |
|
2020
Q4 | $568K | Buy |
4,660
+620
| +15% | +$75.6K | ﹤0.01% | 1403 |
|
2020
Q3 | $352K | Buy |
4,040
+860
| +27% | +$74.9K | ﹤0.01% | 1578 |
|
2020
Q2 | $206K | Buy |
3,180
+640
| +25% | +$41.5K | ﹤0.01% | 1910 |
|
2020
Q1 | $114K | Buy |
+2,540
| New | +$114K | ﹤0.01% | 2146 |
|